June 25, 2018 | Katie Neith
In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.
City of Hope Guides ASCO’s New Geriatric Cancer Recommendations
June 8, 2018 | Saundra Young
City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.
City of Hope receives $2 million grant to promote critical research on aging and cancer
May 31, 2018 | Letisia Marquez
City of Hope has received a five-year award totaling $2 million from the National Institute of Aging to establish a national research infrastructure that will facilitate and support significant innovative projects across the country addressing aging and cancer.
Geriatric assessment guides treatment strategy for older adults with cancer
December 1, 2017 | City of Hope
Researchers developed a self-administered geriatric assessment to identify areas of vulnerability and guide interventions for older adults with cancer.
City of Hope Physicians and Scientists Present Trailblazing Research at Annual ASCO Meeting
June 2, 2017 | Letisia Marquez
City of Hope physicians and researchers are headed to Chicago to present groundbreaking research on blood stem cell transplants for HIV patients, immunotherapies, unique treatment options for older adults battling breast cancer and other topics during the American Society of Clinical Oncology’s (ASCO) 2017 Annual Meeting June 2 to 6.
Four City of Hope Doctors Earn Coveted Distinction
March 17, 2017 | Michael Easterling
Four City of Hope doctors have been named fellows by the American Society of Clinical Oncology (ASCO), an honor bestowed on fewer than 200 of the organization’s more than 40,000 members.
As new City of Hope vice provost, Arti Hurria wants to give back
March 7, 2017 | Letisia Marquez
As new vice provost for clinical faculty for City of Hope, Arti Hurria, M.D., will have primary oversight of academic and faculty affairs for physician faculty in the clinical professor series. She supports City of Hope’s mission to increase the diversity of clinical faculty, and is responsible for designing, implementing and assessing various programs to address faculty diversity, recruitment, retention and advancement.
International women’s day: 7 women changing the world of cancer treatment
March 8, 2016 | City of Hope
At City of Hope, we’re proud to have some of the most talented and passionate women in the medical industry serving at every level of the organization. Here, we’ve spotlighted just a few of the many City of Hope physicians and scientists who are breaking exciting new ground in cancer research, treatment and care.
Meet our doctors: Arti Hurria puts the focus on older cancer patients
February 5, 2016 | Robin Heffler
While the population of the United States continues to age, fueled in large part by medical advances and Baby Boomers, the number of physicians who specialize in treating older patients is on the decline. At the same time, the risk and incidence of cancer increases with age, with approximately 60 percent of all cancers occurring in people over 65.
For seniors with chronic disease, quality medical care is personal
January 21, 2016 | Valerie Howard
Americans are living longer than ever, which means growing numbers of senior citizens are now living with a chronic disease. Since quality of life hinges on the ability to manage these chronic conditions, choosing the right medical care is crucial.
Independent scientific research starts with funding – and mentors
July 23, 2015 | Amanda Traxler
Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising.